Department of Neurosurgery, Affiliated Huashan Hospital, Fudan University, Shanghai, 200042, China.
Department of Nephrology and Rheumatology, Wuxi Children's Hospital, Wuxi, 214023, China.
Biochem Biophys Res Commun. 2019 Feb 5;509(2):585-589. doi: 10.1016/j.bbrc.2018.12.168. Epub 2018 Dec 31.
Intracerebral haemorrhage (ICH) often causes severe neurological deficits in survived patients, although its underlying mechanisms remain elusive. A common feature of ICH is the accumulation of thrombin around the lesion site. Previous studies showed that thrombin promotes VEGF release and angiogenesis at a late stage post ICH [1]. In current study, we explored the source for thrombin-induced VEGF release by adding thrombin or its receptor agonist peptide to the neuronal or astrocytic primarily cultures. We identified that astrocytes specifically respond to thrombin by up-regulating and releasing VEGF. Furthermore, such release is dependent on p44/42 MAPKs and PAR1, a thrombin specific receptor. Our study therefore helps clarifying the underlying mechanisms of thrombin-induced VEGF release in ICH, which will further provide novel insights into the designing principles for treating ICH and traumatic brain injuries.
脑出血 (ICH) 常导致幸存患者严重的神经功能缺损,尽管其潜在机制仍不清楚。ICH 的一个共同特征是在病变部位周围积聚凝血酶。先前的研究表明,凝血酶在 ICH 后晚期促进 VEGF 的释放和血管生成[1]。在本研究中,我们通过向神经元或星形胶质细胞原代培养物中添加凝血酶或其受体激动肽,来探索凝血酶诱导 VEGF 释放的来源。我们发现星形胶质细胞通过上调和释放 VEGF 来特异性地对凝血酶作出反应。此外,这种释放依赖于 p44/42 MAPKs 和 PAR1,即凝血酶的特异性受体。因此,我们的研究有助于阐明 ICH 中凝血酶诱导 VEGF 释放的潜在机制,这将为治疗 ICH 和创伤性脑损伤的设计原则提供新的见解。